JOHN LARSON: Open Payments
NPI 1144783408 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 14 payments from 6 companies in 2025. Trend: 2023 $1,078 · 2024 $801 · 2025 $373
Food & beverage: $302Education: $71
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Teva Pharmaceuticals USA, Inc. | 3 | $113 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Alkermes, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, REXULTI, COBENFY, AUSTEDO XR, VIVITROL, UZEDY, VRAYLAR.
Industry payments across LA — which companies pay providers there.
